NIH Funding Opportunity: Collaborative Research in Fragile X and FMR1-Associated Conditions

NICHD is excited to announce the publication of RFA-HD-20-003: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional).

In recognition of the rapidly evolving landscape of FMR1-associated research, NIH recently published a new Strategic Plan for Research on FMR1-Associated Conditions.  This Strategic Plan, which was developed in collaboration with many members of the Fragile X community, articulates NIH’s current research priorities, which are directed toward an overarching vision of accelerating the development of effective interventions to prevent or treat FMR1-associated conditions. Successful Fragile X Centers will be composed of multidisciplinary teams of basic, translational and clinical investigators collaborating to address complex, difficult-to-solve problems within specific research priorities identified in the Strategic Plan.

Fragile X- Primary Ovarian Insufficiency (FX-POI) Remains A Priority Area For This RFA.

Application Period March 3-April 3, 2020.

An informational webinar is planned in mid-late February for anyone potentially interested in applying under this RFA.  In the meantime, please feel free to reach out to Dr. Susan Taymans (301-496-6517 office; 301-640-6055 cell; or any of the NIH contacts listed in the RFA with any questions.

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew